Scott Centea, Sr. VP/GM Angiodynamics

I love my life, wife, kids and job. I like three day weekends, outdoors and sports. I’m constantly curious.

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

THIS. JUST. HAPPENED. #AlphaVac is NOW cleared for the treatment of Pulmonary Embolism. The OG Large Bore Suction Device is a significant advancement in non-lytic, single session treatment. 🫀🫁💪🏻🫶🏻
@SIRspecialists @SCAI @VascularSVS @angiodynamics

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

PERFECT day to celebrate just how AWESOME the HEART is…for us to live…and love. ⁦@angiodynamics⁩ ⁦@SCAI⁩ ⁦@PERTConsortium⁩ ⁦@American_Heart⁩ ⁦@ACCinTouch⁩ #AngioVac

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

This EXCITING ACHIEVEMENT would not have been possible without the tremendous collaboration of @PERTConsortium , @BrentKeeling & @msran124 , all of the enrolling sites... and of course...our dedicated team members @angiodynamics - THANK YOU

[AngioDynamics, Inc. @angiodynamics]

We are proud to announce the completion of enrollment for the APEX-AV Study, in collaboration with @PERTConsortium! We'd like to extend our deepest gratitude to each of our study sites for their dedication and contributions to this important study.

[AngioDynamics Cardiovascular @AngioDynamicsCV]

We're at #TCT in San Francisco! Be sure you calendar these 2 incredible opportunities to listen from experts in the field on their experience with the #Auryon System.

Want to learn more? Stop by booth 236 - we can't wait to meet you.

[AngioDynamics, Inc. @angiodynamics]

Next week we'll be at #TCT in San Francisco, CA! We are bringing the best of our restorative flow therapy portfolio, including the #AngioVac, #AlphaVac, and the #Auryon Systems. See you there!

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

3 years ago we embarked on a journey of innovation and impact with the launch of our @AuryonPad system. Today we’re raising a toast to the remarkable strides we’ve made in transforming care.
Here’s to the countless lives improved and the dedicated team behind it all!
Thank you.

[AngioDynamics Cardiovascular @AngioDynamicsCV]

Today marks 3 years since @angiodynamics commercially launched the #Auryon System! Since launch, 35,000+ patients have received treatment with this technology. We are incredibly grateful for all of our partners, care teams, field teams, and clinicals for moving PAD care forward.

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

“Oh wow” “Wait, seriously?” “That’s really cool”. “OMG”. “Stop it”
These were just a few comments made by our physician partners after learning of what #Auryon can do in Medial Arterial Calcium.
Thanks @_backtable and @JRUNMD for sharing in our excitement!

[AngioDynamics Cardiovascular @AngioDynamicsCV]

Tune in to this week's @_backtable podcast episode to hear Dr. @JRUNMD discuss the recently published MicroCT Study. Curious on how the Auryon System can change the game in below-the-knee medial calcium? Listen here: https://t.co/nivknljbf0

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

🔥Curious about the buzz around #Auryon? Listen to this exclusive interview with experts 👇🏻 to understand why…or give us us a 📞
#CLIfighters @ISETNews

[AngioDynamics Cardiovascular @AngioDynamicsCV]

Check out this recent interview at #iSET with @arslanmd and @JRUNMD on the MicroCT Study.
https://t.co/5oMgIYYrZy

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

Twitter won’t allow enough characters for me to share just how cool this sophisticated science is for treating PAD…so our cool marketing team made a cool video…👇🏻 ⁦@angiodynamics⁩ ⁦@AuryonPad⁩ ⁦@CLI_Global⁩ #CLI_fighters https://t.co/mQtySQHoB4

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

BIG thanks to @PERTConsortium for another grand event. Excited to be amongst some of the most respected thought leaders in #PE treatment, including our own #APEX PI’s, @msran124 & @BrentKeeling…TY
@angiodynamics @uclaVIR

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

We’ve partnered w/ @StopTheClot for #BloodClotAwarnness I’m incredibly proud of the @angiodynamics team for leading the way in miles logged and funds raised! I knew we had the HEART but didn’t know we had the LEGS! https://t.co/yLNc6MmnEy

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

Education is as powerful of a device as our technologies. Proud of the team for pulling together these important events for our partners. Big thanks to @JonnyMoriarty @zlotnick_david @cardiowiis #angiovac #AlphaVac

[AngioDynamics, Inc. @angiodynamics]

Check out the highlights from our most recent Endovascular Therapies for the Venous System Master Course! We are looking forward to sharing more insights, experiences, & best practices this weekend, live from Tampa, FL! @JonnyMoriarty @cardiowiis @DavidZlotnick1

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

As a new technology, we often measure success through revenue performance and market share gain…but when we step back from those numbers, the ones that matter most become apparent…the lives we help change.
#PAD #CLIfighters #Proud

[AngioDynamics Cardiovascular @AngioDynamicsCV]

Thanks to our partners in healthcare who go above & beyond, over 25,000 patients have been treated since the full commercial launch of the #Auryon System. We are proud to have crossed this milestone in 2022 & we look forward to enhancing treatment options in 2023! #PAD

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

@PERTConsortium Happy Birthday!!!!

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

I wish I was OOO at the @PERTConsortium meeting but joining remotely from my office is helpful. Thank you @msran124 @BrentKeeling @JaafGolzar & Dr. Sabah Butty for executing the audible flawlessly.
#alphavac #PERT #APEX

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

Love this team…and the technology isn’t all that bad either! Thanks guys!
@CLIfighters @AMPSymposium

[AngioDynamics, Inc. @angiodynamics]

As we wrap up #AMPCLI2022, Team Auryon would like to thank everyone who stopped by to learn more about the #Auryon System. For additional information visit https://t.co/BvkP6fd80W

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

@MohammedQintar , Thank you for sharing and for you and your teams continued effort in helping advance care through talented hands and technology. L O V E the “OG” tag as well…perfect!
#LargeBoreOG #CardioTwitter

[Mohammed Qintar, MD MSc @MohammedQintar]

Excited to share our case series on left sided Angiovac @LargeBoreOG mass extraction. This demonstrates the feasibility and safety of such approach and calls for bigger studies to confirm. https://t.co/panEIQxG2L @DeeDeeWangMD @PedroMDMSc @BillONeillMD @MarvinEng3 @TiberioFrisoli

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

Incredibly proud of our "Endovascular Therapies" Sales Team at @angiodynamics who continues to "actually be in the arena"
I love this company, our mission and most importantly...our people our team our family.

#AlphaVac #AngioVac #Auryon #VenaCure

[Scott Centea, Sr. VP/GM Angiodynamics @CenteaScott]

This event signals @angiodynamics commitment to progress #VTE treatment with physician led technology #AlphaVac. The first step in our exciting journey started TOGETHER with @MichaelJolly77 @JoeCampbellMD & @OhioHealth. Sincere thanks & appreciation.

[AngioDynamics, Inc. @angiodynamics]

Congratulations to our partners at @OhioHealth @RiversideHosp on the first-in-human case using the AlphaVac F18 System! We are proud to be your partners in patient care. Learn more about the AlphaVac System at https://t.co/OMW4UY7rSr

https://t.co/iGUj5wlhJc

[SIR RFS @SIRRFS]

Follow along to learn about right atrium vacuum-assisted thrombectomy!

Created by Margerie Arraut MS3 (@MargerieArraut), Dr. Mona Ranade (@msran124), and Tina Chatterjee MS3 (@tinachatterje3)

#TwittIR #IR #IRad #SIR #MedEd